X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (79) 79
humans (67) 67
male (64) 64
female (62) 62
aged (55) 55
middle aged (48) 48
neurology (44) 44
dementia (43) 43
alzheimer's disease (36) 36
neurosciences (34) 34
alzheimers-disease (29) 29
clinical neurology (29) 29
magnetic resonance imaging (29) 29
aged, 80 and over (27) 27
neuropsychological tests (24) 24
brain (20) 20
parkinson's disease (19) 19
atrophy (18) 18
risk factors (18) 18
human necessities (17) 17
hygiene (17) 17
medical or veterinary science (17) 17
preparations for medical, dental, or toilet purposes (17) 17
cognitive ability (16) 16
positron-emission tomography (16) 16
analysis (15) 15
disease progression (15) 15
geriatrics & gerontology (15) 15
memory (15) 15
mild cognitive impairment (15) 15
physics (15) 15
retrospective studies (14) 14
adult (13) 13
blasting (13) 13
dementia disorders (13) 13
dopamine (13) 13
heating (13) 13
lighting (13) 13
mechanical engineering (13) 13
psychiatry (13) 13
weapons (13) 13
brain - pathology (12) 12
cortical thickness (12) 12
foods or foodstuffs (12) 12
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (12) 12
optics (12) 12
pathology (12) 12
preservation of foods or foodstuffs, in general (12) 12
prospective studies (12) 12
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (12) 12
their treatment, not covered by other classes (12) 12
abridged index medicus (11) 11
cognition (11) 11
diagnosis (11) 11
dopamine transporter (11) 11
movement disorders (11) 11
patients (11) 11
age (10) 10
cerebral cortex - pathology (10) 10
medical colleges (10) 10
medical research (10) 10
mri (10) 10
neurodegenerative diseases (10) 10
brain - diagnostic imaging (9) 9
cognitive dysfunction - psychology (9) 9
cortex (9) 9
diagnostic-criteria (9) 9
follow-up studies (9) 9
impairment (9) 9
medicine, experimental (9) 9
age of onset (8) 8
alzheimer disease - pathology (8) 8
article (8) 8
biomedical engineering (8) 8
cohort studies (8) 8
longitudinal studies (8) 8
medicine (8) 8
multidisciplinary sciences (8) 8
positron emission tomography (8) 8
republic of korea (8) 8
risk (8) 8
science (8) 8
aniline compounds (7) 7
cognition disorders - pathology (7) 7
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (7) 7
education (7) 7
frequency-changing (7) 7
functional features or details of lighting devices or systemsthereof (7) 7
lewy bodies (7) 7
neuroimaging (7) 7
non-linear optics (7) 7
non-portable lighting devices (7) 7
oncology (7) 7
optical analogue/digital converters (7) 7
optical elements, systems, or apparatus (7) 7
optical logic elements (7) 7
parkinsons-disease (7) 7
prognosis (7) 7
progression (7) 7
psychology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2010, Volume 107, Issue 51, pp. 22032 - 22037
Journal Article
Human Brain Mapping, ISSN 1065-9471, 09/2019, Volume 40, Issue 13, pp. 3784 - 3794
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 1 - 9
This study aimed to investigate the potential beneficial effects of estrogen on nigrostriatal dopaminergic neuron degeneration in postmenopausal drug-naïve... 
Parkinson's disease | Dopamine | Neurodegenerative diseases | Putamen | Post-menopause | Neurodegeneration | Neostriatum | Dopamine transporter | Hormone replacement therapy | Levodopa | Comparative analysis | Drug dosages | Movement disorders | Dopamine receptors
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 03/2018, Volume 45, Issue 3, pp. 423 - 431
Purpose Reduced presynaptic dopaminergic activity plays an important role in the development of levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD).... 
Dopamine transporter | Levodopa-induced dyskinesia | Parkinson’s disease | PET | Therapy | Parkinson's disease | Dopamine | Neurodegenerative diseases | Positron emission | Regression analysis | Putamen | Patients | Risk factors | Demographics | Neostriatum | Tomography | Levodopa | Transporter | Movement disorders | Dopamine receptors | Dyskinesia | Denervation
Journal Article
STEM CELLS, ISSN 1066-5099, 08/2017, Volume 35, Issue 8, pp. 1934 - 1947
Genome‐wide association studies have identified two loci, SNCA and the microtubule (MT)‐associated protein tau, as common risk factors for Parkinson's disease... 
Mesenchymal stem cell | Parkinson's disease | Eukaryotic elongation factor 1A‐2 | Microtubule | Axonal transport | Autophagy | α‐Synuclein | Eukaryotic elongation factor 1A-2 | α-Synuclein | TAU-SYNUCLEIN | DISEASE MODELS | DOPAMINERGIC-NEURONS | MASS-SPECTROMETRY | RAT MODEL | CELL & TISSUE ENGINEERING | CELL BIOLOGY | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ELONGATION FACTOR-1-ALPHA | STROMAL CELLS | PROTEINS | HEMATOLOGY | alpha-Synuclein | LEWY BODIES | BRAIN | Cell Line | Axonal Transport | Parkinson Disease - pathology | Calmodulin - metabolism | Dependovirus - metabolism | Calcium - metabolism | Humans | Mice, Inbred C57BL | Mesenchymal Stromal Cells - metabolism | Male | Mutation - genetics | Microtubules - metabolism | Animals | Mesenchymal Stromal Cells - ultrastructure | Transfection | Models, Biological | Parkinson Disease - metabolism | alpha-Synuclein - metabolism | Neuroprotection | Phosphorylation | Basal ganglia | Animal models | Calcium | Mesenchyme | Stem cell transplantation | Genomes | Motor task performance | Synuclein | Risk factors | Defects | Proteins | Calcium-binding protein | Assembly | Calmodulin | Elongation | Movement disorders | Dopamine receptors | Cell survival | Dopamine | Neurodegenerative diseases | Health risks | Central nervous system diseases | Risk analysis | Skin & tissue grafts | Stem cells | Cytoskeleton | Mice | Control stability | Transport
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 02/2018, Volume 89, Issue 2, pp. 169 - 174
ObjectivesThe onset of parkinsonism in patients with drug-induced parkinsonism (DIP) exhibits extensive individual variability following exposure to offending... 
drug-induced parkinsonism | dopamine transporter | Parkinson's disease | SURGERY | FLUNARIZINE | SCHIZOPHRENIC-PATIENTS | TYROSINE-HYDROXYLASE | TRANSPORTERS | PSYCHIATRY | CLINICAL-FEATURES | SPECT | CLINICAL NEUROLOGY | INDUCED MOVEMENT-DISORDERS | POSITRON-EMISSION-TOMOGRAPHY | COMPLEX-I | DISEASE | Dopamine Plasma Membrane Transport Proteins - metabolism | Calcium Channel Blockers - adverse effects | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Positron-Emission Tomography | Corpus Striatum - metabolism | Case-Control Studies | Recovery of Function | Parkinsonian Disorders - metabolism | Anticonvulsants - adverse effects | Time Factors | Deprescriptions | Parkinsonian Disorders - diagnostic imaging | Antiemetics - adverse effects | Female | Neostriatum - metabolism | Radiopharmaceuticals | Valproic Acid - adverse effects | Parkinsonian Disorders - physiopathology | Putamen - diagnostic imaging | Serotonin Uptake Inhibitors - adverse effects | Parkinsonian Disorders - chemically induced | Ventral Striatum - metabolism | Caudate Nucleus - metabolism | Tropanes | Caudate Nucleus - diagnostic imaging | Ventral Striatum - diagnostic imaging | Aged | Neostriatum - diagnostic imaging | Fluorine Radioisotopes | Corpus Striatum - diagnostic imaging | Putamen - metabolism | Drugs | Sleep | Dopamine | Medical imaging | Outpatient care facilities
Journal Article
by Yoo, HS and Chung, SJ and Moon, H and Oh, JS and Kim, JS and Hong, JY and Ye, BS and Sohn, YH and Lee, PH
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 03/2018, Volume 45, Issue 3, pp. 423 - 431
Purpose Reduced presynaptic dopaminergic activity plays an important role in the development of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD).... 
NONLINEAR PROGRESSION | 5-YEAR | Parkinson's disease | ROPINIROLE | Levodopa-induced dyskinesia | PATHOPHYSIOLOGY | MOTOR FLUCTUATIONS | IMPACT | CELLULAR-PARAMETERS | Dopamine transporter | GENDER | MONKEYS | BINDING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P1524 - P1524
Journal Article